These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 23709725

  • 21. Target-specific oral anticoagulants: practice issues for the clinician.
    Plitt A, Giugliano RP.
    Hosp Pract (1995); 2014 Aug; 42(3):48-61. PubMed ID: 25255406
    [Abstract] [Full Text] [Related]

  • 22. ["Xa-tra-xa": opportunities and open questions about new anticoagulants].
    Beer JH.
    Praxis (Bern 1994); 2011 Aug 10; 100(16):947. PubMed ID: 21910293
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. ARISTOTLE RE-LYs on the ROCKET. What's new in stroke prevention in patients with atrial fibrillation?
    Tendera M, Syzdół M, Parma Z.
    Cardiol J; 2012 Aug 10; 19(1):4-10. PubMed ID: 22298161
    [Abstract] [Full Text] [Related]

  • 29. [Improvements in oral anticoagulant therapy for atrial fibrillation].
    Briongos Figuero S, García Santos-Gallego C, Badimón JJ.
    Med Clin (Barc); 2013 Dec 07; 141(11):487-93. PubMed ID: 23597953
    [Abstract] [Full Text] [Related]

  • 30. [Differential therapy with the new anticoagulants, 5].
    Stiefelhagen P.
    MMW Fortschr Med; 2013 May 16; 155(9):20. PubMed ID: 23951642
    [No Abstract] [Full Text] [Related]

  • 31. New alternative anticoagulants in atrial fibrillation: the move beyond warfarin.
    Bhimani AA, Hong M.
    Rev Recent Clin Trials; 2013 Jun 16; 8(2):78-85. PubMed ID: 23859143
    [Abstract] [Full Text] [Related]

  • 32. Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.
    Aryal MR, Ukaigwe A, Pandit A, Karmacharya P, Pradhan R, Mainali NR, Pathak R, Jalota L, Bhandari Y, Donato A.
    Am J Cardiol; 2014 Aug 15; 114(4):577-82. PubMed ID: 24998087
    [Abstract] [Full Text] [Related]

  • 33. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Olesen JB, Sørensen R, Hansen ML, Lamberts M, Weeke P, Mikkelsen AP, Køber L, Gislason GH, Torp-Pedersen C, Fosbøl EL.
    Europace; 2015 Feb 15; 17(2):187-93. PubMed ID: 25236181
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS, Lip GY.
    Best Pract Res Clin Haematol; 2013 Jun 15; 26(2):115-29. PubMed ID: 23953900
    [Abstract] [Full Text] [Related]

  • 36. [New anticoagulants: better knowledge, better prescriptions].
    Boehlen F, de Moerloose P.
    Rev Med Suisse; 2012 Jan 18; 8(324):96-9. PubMed ID: 23185817
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Novel anticoagulants eliminate the need for left atrial appendage exclusion devices.
    Ezekowitz MD, Kent AP.
    Circulation; 2014 Oct 21; 130(17):1505-14. PubMed ID: 25332278
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Concerns about studies investigating new anticoagulant drugs for stroke prevention in atrial fibrillation.
    Stöllberger C, Finsterer J.
    J Neurol; 2012 Jan 21; 259(1):168-9. PubMed ID: 22124666
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.